Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistance, Neoplasm | 8 | 2020 | 5172 | 0.910 |
Why?
|
| bcl-X Protein | 4 | 2019 | 411 | 0.710 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2022 | 3524 | 0.690 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 182 | 0.660 |
Why?
|
| Heme | 1 | 2019 | 307 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2019 | 1434 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2022 | 2504 | 0.500 |
Why?
|
| Apoptosis | 6 | 2023 | 9724 | 0.410 |
Why?
|
| Sulfonamides | 3 | 2019 | 1940 | 0.390 |
Why?
|
| Antineoplastic Agents | 5 | 2023 | 13693 | 0.250 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2022 | 18 | 0.220 |
Why?
|
| Oncogene Proteins v-abl | 1 | 2021 | 22 | 0.210 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4208 | 0.200 |
Why?
|
| Karyopherins | 1 | 2022 | 137 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1692 | 0.200 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 16690 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 1525 | 0.180 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 63 | 0.170 |
Why?
|
| HL-60 Cells | 1 | 2020 | 365 | 0.170 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2019 | 38 | 0.170 |
Why?
|
| Transaldolase | 1 | 2018 | 9 | 0.170 |
Why?
|
| Interferon Type I | 1 | 2023 | 542 | 0.170 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 284 | 0.170 |
Why?
|
| Genetic Fitness | 1 | 2020 | 121 | 0.170 |
Why?
|
| Electron Transport | 1 | 2019 | 211 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 297 | 0.150 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 174 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 871 | 0.150 |
Why?
|
| Acoustics | 1 | 2018 | 240 | 0.140 |
Why?
|
| Neoplasms | 3 | 2020 | 21696 | 0.140 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 553 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.130 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 913 | 0.130 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 107 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2021 | 5534 | 0.120 |
Why?
|
| Biological Evolution | 1 | 2020 | 1077 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 428 | 0.120 |
Why?
|
| Environment | 1 | 2020 | 1123 | 0.120 |
Why?
|
| Folic Acid | 1 | 2020 | 1300 | 0.120 |
Why?
|
| Colorectal Neoplasms | 3 | 2019 | 6773 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 1312 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 2019 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2014 | 528 | 0.100 |
Why?
|
| Mice | 7 | 2022 | 81201 | 0.090 |
Why?
|
| ras Proteins | 1 | 2014 | 1060 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1636 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2417 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2014 | 606 | 0.080 |
Why?
|
| Cell Line | 2 | 2020 | 16000 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2182 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3255 | 0.070 |
Why?
|
| Animals | 8 | 2022 | 168768 | 0.070 |
Why?
|
| Mitochondria | 1 | 2019 | 3514 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2020 | 647 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5856 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 23404 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1832 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3554 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5263 | 0.050 |
Why?
|
| Phenotype | 1 | 2020 | 16367 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11525 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 220 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2023 | 758 | 0.050 |
Why?
|
| U937 Cells | 1 | 2020 | 268 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 408 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12207 | 0.050 |
Why?
|
| Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2019 | 200 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 409 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 124 | 0.040 |
Why?
|
| Humans | 12 | 2021 | 744366 | 0.040 |
Why?
|
| NADP | 1 | 2018 | 226 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 1794 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2018 | 158 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13104 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 968 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3689 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 988 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 624 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1707 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6386 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20824 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4851 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 1793 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2725 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2383 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2018 | 3444 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2566 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14561 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2916 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 5882 | 0.020 |
Why?
|
| Mutation | 2 | 2020 | 29786 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13035 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21833 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.010 |
Why?
|
| Male | 2 | 2020 | 350115 | 0.010 |
Why?
|
| Female | 1 | 2018 | 380193 | 0.000 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_